Ibrutinib‐associated invasive fungal diseases in patients with chronic lymphocytic leukaemia and non‐Hodgkin lymphoma: An observational study

Mycoses ◽  
2019 ◽  
Vol 62 (12) ◽  
pp. 1140-1147 ◽  
Author(s):  
Rosa Ruchlemer ◽  
Ronen Ben‐Ami ◽  
Maskit Bar‐Meir ◽  
Jennifer R. Brown ◽  
Marion Malphettes ◽  
...  
Keyword(s):  
Observational Study ◽  
Chronic Lymphocytic Leukaemia ◽  
Hodgkin Lymphoma ◽  
Lymphocytic Leukaemia ◽  
Fungal Diseases ◽  
Non Hodgkin Lymphoma ◽  
Invasive Fungal Diseases

scholarly journals Voxtalisib (XL765) in patients with relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukaemia: an open-label, phase 2 trial

2018 ◽  
Vol 5 (4) ◽  
pp. e170-e180 ◽  
Author(s):  
Jennifer R Brown ◽  
Mehdi Hamadani ◽  
John Hayslip ◽  
Ann Janssens ◽  
Nina Wagner-Johnston ◽  
...  
Keyword(s):  
Chronic Lymphocytic Leukaemia ◽  
Hodgkin Lymphoma ◽  
Lymphocytic Leukaemia ◽  
Phase 2 ◽  
Open Label ◽  
Non Hodgkin Lymphoma ◽  
Phase 2 Trial ◽  
Open Label Phase

Mechanisms of ibrutinib resistance in chronic lymphocytic leukaemia and non-Hodgkin lymphoma

2015 ◽  
Vol 170 (4) ◽  
pp. 445-456 ◽  
Author(s):  
Shuang Q. Zhang ◽  
Sonali M. Smith ◽  
Shuang Y. Zhang ◽  
Yue Lynn Wang
Keyword(s):  
Chronic Lymphocytic Leukaemia ◽  
Hodgkin Lymphoma ◽  
Lymphocytic Leukaemia ◽  
Non Hodgkin Lymphoma ◽  
Ibrutinib Resistance

Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study

2019 ◽  
Vol 6 (2) ◽  
pp. e67-e78 ◽  
Author(s):  
Anas Younes ◽  
Joshua Brody ◽  
Cecilia Carpio ◽  
Armando Lopez-Guillermo ◽  
Dina Ben-Yehuda ◽  
...  
Keyword(s):  
Chronic Lymphocytic Leukaemia ◽  
Hodgkin Lymphoma ◽  
Lymphocytic Leukaemia ◽  
Phase 1 ◽  
Non Hodgkin Lymphoma
Sign in / Sign up

Export Citation Format

Share Document